Introduction
Nitric oxide is synthesised from the cationic amino acid L-arginine via a series of oxidation reactions which produce L-citrulline as a co-product. In rat cultured aortic smooth muscle cells (RASMC), the metabolism of L-arginine to NO and L-citrulline is mediated by Ca 2+ /calmodulin-insensitive NO synthase (iNOS) (Knowles & Moncada, 1994; Alderton et al., 2001) , which is induced following exposure of these cells to pro-inflammatory mediators (Wileman et al., 1995) . Once induced, sustained synthesis of NO by iNOS is critically dependent on the availability of extracellular L-arginine (Escobales et al., 2000; Schott et al., 1993) and, as a consequence, supply of L-arginine may become limiting for NO production.
Under physiological conditions most plasma L-arginine is derived from metabolism of L-citrulline by the kidneys (Windmueller & Spaeth, 1981; Dhanakoti et al., 1990) , and is transported into cells via selective cationic amino acid transporters (Devés & Boyd, 1998; Palacin et al., 1998; Closs & Mann, 1999; Mann et al., 2003) . In vascular smooth muscle, L-arginine can also be generated endogenously from Lcitrulline. These cells, although lacking a complete urea cycle, express argininosuccinate synthase (AS) and argininosuccinate lyase (AL) (Hattori et al., 1994) , which respectively catalyse the synthesis of argininosuccinate from L-citrulline and the cleavage of argininosuccinate to L-arginine and fumarate (Meijer et al., 1990) . The capacity of these enzymes to regenerate L-arginine from L-citrulline may represent a rate-limiting mechanism in smooth muscle cells for maintaining substrate supply during sustained NO synthesis. Of direct relevance to this is the fact that AS, the rate limiting enzyme in the pathway, is markedly enhanced in smooth muscle cells expressing iNOS (Hattori et al., 1994) . Moreover, the induction of AS parallels that of iNOS indicating coordinated regulation of both proteins with perhaps a close functional relationship where enhanced AS expression drives the metabolism of L-citrulline to L-arginine, sustaining substrate supply for iNOS. In agreement with this hypothesis, L-citrulline has been reported to induce NOdependent vasorelaxation in denuded aortic rings isolated from endotoxin treated rats (Raghavan & Dikshit, 2001) and to sustain maximal rates of NO production in cultured aortic smooth muscle cells activated with bacterial lipopolysaccharide (LPS) and interferon-γ (IFN-γ) (Hattori et al., 1994) . In the latter study, it is worth noting that concentrations of L-citrulline required (EC 50 = 600 µM) for optimal iNOS activity were however 20-fold higher than the predicted K m for purified AS (Meijer et al., 1990) . This finding, together with the fact that vascular responses to L-citrulline developed slowly, requiring 45 min to reach a maximum (Raghavan & Dikshit, 2001) , potentially highlights a limitation in cellular uptake of L-citrulline.
Currently, transport of L-citrulline into vascular cells is poorly understood, with only two reports describing distinct pathways for L-citrulline transport in macrophages (Baydoun et al., 1994) and neural cell cultures (Schmidlin et al., 2000) . To our knowledge the mechanisms mediating L-citrulline transport in vascular smooth muscle cells have not been investigated. In view of the potential role of L-citrulline in regulating NO synthesis and vascular tone under physiological and pathophysiological conditions, we have characterized the system(s) mediating L-citrulline transport into smooth muscle cells cultured from rat aorta and investigated the dependency of iNOS on extracellular L-arginine and L-citrulline. Furthermore, we have examined whether L-citrulline transport is regulated by pro-inflammatory mediators by examining the effects of LPS in combination with IFN-γ.
Materials and Methods

Materials
Tissue culture reagents were purchased from Gibco (Paisley, UK). Recombinant murine IFN-γ was from Genzyme (Cambridge, UK). Monoclonal anti-α smooth muscle actin, L-citrulline, and LPS from Escherichia coli (serotype 0111:B4) were obtained from Sigma (Poole, UK 
Cell culture
Smooth muscle cells (SMC) were isolated from rat aortic explants as described previously (see Wileman et al., 1995) . Briefly, male Sprague-Dawley rats (250-300 g) were stunned and exsanguinated and the thoracic aorta dissected in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 4.4% NaHCO 3 , penicillin (100 units ml Following removal of the adventitia and endothelium, each aorta was cut into 2 mm 2 segments and placed in a T-25 tissue culture flask containing DMEM, supplemented with 2 mM glutamine and 10 % foetal calf serum. Explants were left in culture for 14 days, after which migrating and rapidly dividing cells were harvested with trypsin/EDTA (0.01/0.02%) and cultured to confluence in a T-75 flask. Cell were identified and characterized as SMC by immunostaining of smooth muscle α-actin, using mouse anti-α-actin antibody and anti-mouse IgG FITC conjugate (Sigma, Poole, Dorset, UK), as described by Skalli et al. (1986) . All experiments were performed using cells between passages 4 and 7.
Activation of cells with lipopolysacchride and interferon-γ
Rat aortic SMC were plated into 96 well plates at a seeding density of 8x10 3 cells per well and allowed to grow to confluence. The culture medium was then replaced either with fresh medium or with medium containing LPS (100 μg ml -1 ) plus IFN-γ (50 U ml -1
). Cells were incubated for a further 24 h, after which the supernatant was removed from each well and analysed for nitrite, and transport of L-[ 14 C]citrulline (1 µCi ml -1 , 37°C, 0-10 min) determined in cell monolayers incubated with Krebs solution (Wileman et al., 1995) .
To investigate the dependency of NO synthesis on extracellular L-arginine or Lcitrulline, confluent SMC monolayers in 96 well plates were activated for 24 h with LPS and IFN-γ in the presence of increasing concentrations of either L-arginine (0-1 mM) or in Larginine-free medium supplemented with increasing concentrations of L-citrulline (0-1 mM).
Culture medium was removed after the incubation period and analysed for nitrite. Total protein content of each cell monolayer was determined using Brilliant Blue G reagent (Bradford, 1976) .
L-citrulline transport assay
Cell monolayers were rinsed twice with a Hepes-buffered Krebs solution (mM: NaCl: 131; KCl:
5.5; MgCl 2 : 1; CaCl 2 : 2.5; NaHCO 3 : 25; NaH 2 PO 4 : 1; D-glucose: 5.5; Hepes: 20; pH 7.4) maintained at 37 o C. As described previously (Wileman et al., 1995) , transport of L- NaOH to achieve pH values ranging between pH 5 -8. In sodium-free experiments, Krebs buffer was modified by replacing NaCl, NaHCO 3 and NaH 2 PO 4 with choline chloride, choline bicarbonate and KH 2 PO 4 , respectively. In some experiments an extracellular reference tracer, D-[ 3 H]mannitol, was included in the incubation medium and in these studies < 0.01% of Dmannitol applied was recovered in cell lysates.
Tracer uptake was terminated by placing the 96 well plates on ice and rinsing the cell monolayers three times with 200 μl ice-cold Krebs containing 10 mM unlabelled L-citrulline.
Cell protein was determined using Brilliant Blue G and radioactivity (dpm) in formic acid digests of the cells was determined by liquid scintillation counting. Transport was then calculated and expressed as pmol μg protein -1 min -1
.
Nitrite analysis
Nitrite accumulation in the culture medium was determined colorimetrically by a diazotization reaction using the standard Griess reagent (Green et al., 1982; Wileman et al., 1995) .
Analysis of intracellular amino acid concentrations
L-arginine and L-citrulline concentrations in rat cultured aortic smooth muscle cells were determined by reversed-phase hplc. Confluent monolayers from unstimulated or LPS (100 mg
) treated cells were incubated in either L-arginine-containing or Larginine-deprived medium. Following a 24 h incubation period, the culture medium was removed, and the cell monolayer washed twice with ice-cold PBS, lysed with 0.5 ml ice-cold methanol and stored at -20°C for analysis, as described previously (Baydoun et al., 1990) .
Statistics
Data are expressed as means ± S.E.M. of measurements in at least three different cell cultures with 5-6 replicates per experiment. Statistical analyses were performed using either an unpaired Student's t-test or by analysis of variance when necessary with the overall confidence levels set at 95% (0.05).
Results
Time-course and kinetics of L-citrulline transport
Transport of L-citrulline (0.1 mM) into rat aortic smooth muscle cells (RASMC) was timedependent and linear for up to 30 min (see Fig. 4B in Wileman et al., 1995) . Cells accumulated <0.5 pmol L-citrulline per µg protein in 1 min. In all subsequent experiments, transport was measured over a 10 min incubation period to maximize tracer activity in smooth muscle cell digests. In unstimulated smooth muscle cells, transport of L-citrulline (0.05 -5 mM) was fitted best by a single Michaelis-Menten equation, with an apparent K m of 1.6 ± 0.2 mM and V max of 5.9 ± 0.6 pmol μg -1 protein min-1 (Fig. 1) . Pretreatment of smooth muscle cells with LPS (100 mg ml
) for 24 h had no significant effect on either V max (6.9 ± 0.9 pmol μg -1 protein min -1 ) or K m (2.4 ± 0.4 mM).
Characteristics of L-citrulline transport
In both unstimulated and LPS/IFN-γ activated cells, transport of L-citrulline was partially dependent on extracellular Na + but unaffected by changes in extracellular pH ranging from 5-8 (Table 1) . Transport was significantly inhibited by a 10-fold excess of unlabelled Lcitrulline (K i = 0.4 mM), 2-aminobicycloheptane-2-carboxylic acid (BCH; model substrate for system L; K i = 0.2 mM) or 6-diazo-5-oxo-L-norleucine (DON; model substrate for system N;
substrates for systems A and x c -/X AG respectively, were ineffective inhibitors, whilst L-arginine, a substrate for cationic amino acid transporters (CATs), caused only marginal (18 %) inhibition (Table 2 ).
Detailed analysis of the inhibition of L-citrulline transport by L-citrulline, BCH or DON revealed that each compound inhibited transport in a concentration-dependent manner, reducing L-citrulline uptake by 67 ± 4%, 76 ± 2% and 80 ± 0.4% at 5 mM (Fig 2) . In contrast, the marginal inhibition caused by 1 mM L-arginine was not further enhanced by increasing extracellular L-arginine to 5 mM (Fig 2) .
Dependency of nitrite production on extracellular L-citrulline
To investigate whether extracellular L-citrulline could sustain NO production by iNOS, RASMCs were activated with LPS (100 μg ml Activation of cells in the presence of exogenous L-arginine caused a concentrationdependent increase in accumulated nitrite levels. This response was near maximal at plasma Larginine concentrations (~100 µM, see Baydoun et al., 1990; Hallemeesch et al., 2002; Mann et al., 2003) , leveling off at 300 μM nitrite (Fig 3) . In contrast to L-arginine, increasing concentrations of L-citrulline failed to sustain maximal NO production. More importantly, there was no detectable nitrite produced at plasma concentrations of L-citrulline (~30 µM, see Castillo et al., 1993) and at 1 mM, the maximum levels of nitrite detected in the culture medium were approximately one third those produced in the presence of the same concentration of L-arginine (Fig 3) .
Chromatographic analyses of cell lysates obtained from smooth muscle cells deprived of L-arginine for 24h revealed a decrease in intracellular L-arginine levels from 1.43 mM to 260 μM (Table 3 ). In cells activated with LPS and IFN-γ for 24h, intracellular L-arginine levels decreased to 760 μM whilst intracellular L-citrulline levels increased to 3.19 mM, consistent with an enhanced production of NO via iNOS. In the absence of extracellular L-arginine, intracellular L-arginine and L-citrulline levels decreased and were maintained at 300 μM and 40 μM, respectively following activation (Table 3) .
Discussion
L-citrulline has emerged as an important amino acid both as a product of the urea cycle and as a precursor for L-arginine biosynthesis within the vasculature. In vivo citrulline is synthesized and released from the intestine as an end product of L-glutamine nitrogen metabolism (Windmueller & Spaeth, 1981) . Once in the circulation L-citrulline is rapidly cleared by the kidney and subsequently metabolised and released as L-arginine (Windmueller & Spaeth, 1981; Dhanakoti et al., 1990) . In addition to this pathway, various cells within the vasculature possess a truncated urea cycle, expressing both argininosuccinate synthase and argininosuccinate lyase, which respectively catalyze the metabolism of citrulline to argininosuccinate and then L-arginine. The presence of these enzymes has led to the suggestion that cells may be able to recycle L-citrulline, thereby maintaining cellular concentrations of L-arginine for sustained NO synthesis (Hattori et al., 1994; Raghavan & Dikshit, 2001) . Consistent with this hypothesis, conversion of L-citrulline to L-arginine is enhanced in endothelial cells stimulated to release NO (Hecker et al., 1990a; Hecker et al., 1990b) , and in macrophages (Baydoun et al., 1994; Wu & Brosnan, 1992) and smooth muscle cells (Hattori et al., 1994) generating NO following activation with pro-inflammatory mediators.
It would appear however that the effectiveness of L-citrulline to maintain adequate substrate supply for NOS may be limited by its ability to enter cells. Transport of L-citrulline into rat aortic smooth muscle cells (RASMC) is slow, remaining linear over a period of up to 30 min. At physiological plasma concentrations, initial rates of L-citrulline transport are 3-fold lower than rates measured previously for L-arginine (Wileman et al., 1995) . Unlike Larginine, kinetic analysis revealed that transport is mediated via a low affinity carrier (K m ~1.6 mM), which may limit uptake from plasma in the presence of other circulating competitor amino acids. The lower rate of transport together with the relatively low affinity of the transporter could explain the slow onset of action of L-citrulline in inducing relaxation of preconstricted aortic rings (Raghavan & Dikshit, 2001 ) and could also account for the significantly high concentrations of exogenous L-citrulline required to sustain maximal iNOS activity in cultured smooth muscle cells (Hattori et al., 1994) .
Kinetic cross-inhibition experiments suggest that the transporter for L-citrulline in RASMC is distinct from the cationic amino acid transporters mediating L-arginine entry in this cell type. First, transport of L-citrulline was not significantly altered by a 10-50 fold excess of L-arginine. Second, transport was also unaffected by LPS and IFN-γ, which are both known to increase L-arginine transport in various cell types including rat aortic smooth muscle cells (Wileman et al., 1995; Durante et al., 1995) . The insensitivity of L-citrulline transport to pro-inflammatory mediators is consistent with our previous findings in J774 macrophages (Baydoun et al., 1994) and with reports in neuronal cell cultures (Schmidlin et al., 2000) .
The fact that L-arginine failed to cause a significant modulation of L-citrulline transport in RASMC also rules out a role for the broad-scope amino acid transporters such as the Na + -dependent system B o,+ or the Na + -independent system b o,+ capable of transporting both neutral and basic amino acids (Van Winkle et al., 1988; Van Winkle et al., 1985) .
Moreover, the low affinity for L-citrulline transport excludes a significant contribution of the high affinity system y + L identified in several different cell types (reviewed by Devés & Boyd, 1998; Devés & Boyd, 2000; Wagner et al., 2001 ) including a recent study in human endothelial cells (Sala et al., 2002) . Instead, our findings suggest that transport of L-citrulline in RASMC may be mediated predominantly via a carrier with characteristics similar to system L.
The classical Na + -independent transport system L is most reactive with branched chain and aromatic neutral amino acids and is often characterised using the selective nonmetabolisable analog BCH (Christensen et al., 1969; Shotwell et al., 1983) . Transport via system L is trans-stimulated by intracellular substrates of this carrier and in some cases may be increased by lowered extracellular pH. Studies in rat glioma cells, primary astroglial cells and lymphocytes suggested that 4F2hc serves as a necessary component for expression of system L-like transport activity (Bröer et al., 1995) . Co-expression of 4F2hc and LAT-1 or LAT-2 (system L transporters) in oocytes induces Na + -independent transport with a broad specificity for small and large zwitterionic amino acids and sensitivity to trans-stimulation (Kanai et al., 1998; Pineda et al., 1999) . The marked inhibition of L-citrulline transport by BCH and the trend for increased transport at lowered pH implicates system L as the major transporter L-citrulline uptake in RASMC. This may not however be the only system that is (Wu et al., 2001 ) may well account for the reduction of NO synthesis reported in both intact cell systems (Hecker et al., 1990a; Wu & Meininger, 1993 ) and blood vessels (Swierkosz et al., 1990) .
Entry via systems L and N or, an as yet unidentified, carrier with properties similar to system L and/or N, could explain why, in the absence of extracellular L-arginine, L-citrulline was not able to maintain maximal rates of NO production in our studies. Several other amino acids utilise systems L and N for entry into cells. Some of these amino acids, including Lphenylalanine and L-glutamine are present in high concentrations in various culture media, including Dulbecco's modified Eagle's medium. Thus under standard experimental conditions, uptake of L-citrulline will be impaired by competing amino acids, with their combined effect causing marked inhibition of L-citrulline transport. Under these conditions, the capacity of cells to recycle L-arginine from L-citrulline would also be limited because other neutral amino acids will inhibit uptake of L-citrulline by competing for the same transporter(s) that facilitate entry of citrulline into cells. As a result, regeneration of Larginine would not be efficiently maintained to match the consumption by NOS, even if the capacity of argininosuccinate synthase and argininosuccinate lysase to generate L-arginine from L-citrulline may be sufficient for maintaining maximal rates of NO synthesis (Hattori et al., 1994) . The finding that in LPS and IFN-γ activated cells with depleted intracellular Lcitrulline and L-arginine levels (Table 3) , only limited nitrite is released in the presence of 1 mM extracellular L-citrulline (Fig. 3) , indicates that L-citrulline transport cannot maintain maximal NO synthesis. It is also possible that L-citrulline available to arginosuccinate synthase and arginosuccinate lyase is compartmentalized and not readily exchangable with transported L-citrulline.
Activation of L-arginine transport in vascular smooth muscle cells by proinflammatory cytokines (Wileman et al., 1995; Durante et al., 1995) provides a mechanism for sustaining L-arginine supply during enhanced utilisation by iNOS. Even though low intracellular L-arginine levels (300 μM) in L-arginine deprived cells would be expected to sustain NO synthesis, it is possible that as in macrophages (Closs et al., 2000) a non-freely exchangeable L-arginine pool is not accessible to iNOS. Under these conditions, and as demonstrated in the present study, transport of L-arginine becomes rate-limiting for NO production. This hypothesis is further supported by the finding that iNOS mediated NO production is reduced significantly in macrophages from CAT2 -,-mice (Nicholson et al., 2001 ). This report and our present findings strongly suggest a functional association between CAT2 and iNOS, with a critical dependency of NO production on L-arginine delivery.
The inability of cytokines to stimulate L-citrulline transport in RASMC suggests that delivery of L-citrulline will not occur at a sufficiently high rate to maintain adequate levels of L-arginine for optimal iNOS activity. L-citrulline would therefore be far less effective than Larginine in supporting NO synthesis, maintaining, at best, a fraction of the maximal rate of NO synthesis induced by L-arginine, as demonstrated in this and other studies in macrophages (Baydoun et al., 1994; Wu & Brosnan, 1992) . The lack of potentiation of L-citrulline transport by pro-inflammatory cytokines is another limiting factor worth taking into account when evaluating the potential of L-citrulline in maintaining the generation of NO via iNOS.
In summary, our findings establish that uptake of L-citrulline by RASMC is mediated via amino acid transport systems with properties characteristic of systems L and N. Inhibition by circulating amino acids will restrict the entry of L-citrulline into vascular cells and thereby limit the amount of intracellular L-arginine generated from this source. As a result, Lcitrulline has only a limited ability to sustain maximal rates of NO synthesis both in vitro and in vivo. 
